New guy hereNew to the company but the way I see it, there are 3 possible outcomes to the FDA situation:
1-Get approval, can't see this happening yet but would not upset me the least.
2-Get formal denial-CANNOT see this happen at all
3-Path forward explained by the FDA, ie what must the company do to obtain FDA approval-This is what I do expect and would be a positive catalyst for the share price.
We have plenty of money in the bank to move forward and do more studies without further dilution. At the current share price, I think the upside far outweighs the downside.
Let's see what the rest of the week brings us.
DD